University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 31 of 35
Effect of Cocoa Flavanols on Vascular Function
NCT00553774
Adherence and the Economics of Colon Cancer Screening
NCT00705731
The Impact of Lymphedema on Breast Cancer Survivors
NCT00769821
MEG and DTI of Neural Function and Connectivity in Traumatic Brain Injury
NCT01298557
Evaluating a Distance Learning Asthma Education Program for Pediatricians (The DALI Study)
NCT00815724
Sonographic Assessment and Visualization of Ectopics in Emergency Medicine
NCT01322958
Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus
NCT00501709
Biomarker Study for Heart Failure in Children With Single Ventricle Physiology
NCT00571233
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
NCT00501696
Dyspnea Self-Management: Internet or Face-to-Face
NCT00461162
Cotinine Metabolism in Infants and Children
NCT00994591
Comparison of CT Angiography With Conventional Angiography and Intravascular Ultrasound in Heart Transplant Patients
NCT00723281
Educational Program to Improve Heart Failure Outcomes in Adults Living in Rural Areas
NCT00415545
Study on Use of Xylitol-wipes to Prevent Dental Caries
NCT01468727
Use of 3-D Blood Pool Scintigraphy to Guide Left Ventricular Pacing Lead Placement in Patients Requiring Cardiac Resynchronization Therapy
NCT02669290
Craving and Lifestyle Management Through Mindfulness Study
NCT01250509
Induction of Labor With a Foley Balloon Catheter: Inflation With 30ml Compared to 60ml
NCT00451308
Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge
NCT00373412
Sorafenib and RAD001 Renal Cell Carcinoma
NCT00384969
Yoga for the Treatment of Metabolic Syndrome
NCT00605436
HIV Testing Strategies in the Perinatal Setting
NCT00503308
Reducing Disparities in Diabetes Risk Through Lifestyle Changes in Community Settings
NCT00770926
" Patients Attitude Towards Physicians and Health Screening Issues Among First Generation Asian-Indian Immigrants to United States".
NCT00378430
Valganciclovir to Reduce T Cell Activation in HIV Infection
NCT00264290
Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors
NCT00390156
MR Imaging of Knee Osteoarthritis and Acute Knee Injuries
NCT00504114
Intensive Intervention for Smokers - 6
NCT00217984
Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer
NCT00416403
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
NCT00501943
GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer
NCT00305669
A Mindfulness Based Approach to HIV Treatment Side Effects
NCT00312936
Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
NCT00410774
The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA
NCT00739921
A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome
NCT00862576
The Use of rFVIIa in Trauma Patients: A Multi-Center Case Registry
NCT00328133
The Health in Pregnancy (HIP) Study
NCT00540319
Protocols for Improved in Vitro Fertilization (IVF) Outcomes
NCT00334243
Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With Placebo
NCT00352651
Educational Intervention on Weight Management in Chinese-American Children
NCT00522964
Impact of Using Mini-Bronchoalveolar Lavage as a Diagnostic Test for Ventilator-Associated Pneumonia
NCT00319644
Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement
NCT00333437
Does Bone Structure Explain the Increased Fracture Risk in Type II Diabetes Patients? A Pilot Study
NCT00703417
Opioid and Cannabinoid Pharmacokinetic Interactions
NCT00308555
Mechanisms of Exacerbation of Asthma
NCT00594750
The Use of Tissue Oxygen Monitoring in Critically Injured Patients
NCT00328341
Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer
NCT00616122
Validation of Dietary Calcium Questionnaires Using Diet Records
NCT00512733
Alpha Lipoic Acid and Polycystic Ovary Syndrome
NCT00505427
Modafinil-Alcohol Interactions in Healthy Volunteers
NCT00305292
Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women
NCT00504166
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.